Frequency of anxiety and depression in patients with melasma

Kalsoom Jawaid, Muhammad Shahid, Kehkshan Tahir, Nadia Ali, Asma Tariq, Abid Hussain

Abstract


Background Melasma is a common acquired hypermelanosis characterized by irregular brown patches occurring primarily on the forehead, cheeks and chin in a mask-like distribution. Melasma most commonly affects women of reproductive age.  This chronic and recurrent condition causes a deleterious impact on various domains of patients’ quality of life.

 

Objective To determine the frequency of anxiety and depression in patients with melasma.

 

Methods A total of 195 cases of both gender with melasma and ages between 20-40 years were enrolled through non-probability consecutive sampling. Detailed history and examination were done. Hospital Anxiety and Depression Scale (HADS) was administered to all the patients. Scoring of anxiety and depression was done individually for each patient.

 

Results Out of 195 cases, 37% (n=73) were between 20-30 years of age and 63%(n=122) were of 31-40 years. Thirty-six patients (18.46%) were male and 159 (81%) were females. Frequency of anxiety in patients with melasma was recorded as 19.49% (n=38) and 10.77% (n=21) had depression.

 

Conclusion The frequency of anxiety and depression is high among patients with melasma. It is, therefore, recommended that patients who present with melasma may be evaluated for anxiety and depression severity and clinicians should have proper surveillance system to document the frequency of this problem.

 


Keywords


Melasma, anxiety, depression

Full Text:

PDF

References


Bandyopadhyay D. Topical treatment of melasma. Indian J Dermatol 2009; 54: 303–9.

Passeron T. Melasma pathogenesis and influencing factors-an overview of the latest research. J Eur Acad Dermatol Venereol 2013; 27: 5-6.

Ponzio HAS. Contribuição à classificação clínica e histopatológica dos melasmas [dissertação]. Porto Alegre: UFRGS; 1995. p. 157.

Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003; 149: 572-7.

Dominguez AR, Balkrishnan R, Ellzey AR, Pandya AG. Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language. J Am Acad Dermatol 2006; 55: 59-66.

Ponzio HAS, Cruz MF. Acurácia do exame sob a lâmpada de Wood na classificação dos cloasmas. An Brás Dermatol 1993; 68: 325-8.

Purim KS, Avelar MF. Photoprotection, Melasma and quality of life in pregnant women. Rev Bras Ginecol Obstet 2012; 34(5): 228-34.

Ali R, Aman S, Nadeem M, Kazmi AH. Quality of life in patients of melasma. J Pak Assoc Dermatol 2013; 23: 143-8.

Aslam R, Qadir A, Asad F. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. J Pak Assoc Dermatol 2007; 17: 235-9.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.

Sampogna F, Picardi A, Chren MM. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004; 66: 620–4.

Bashir K, Dar NR, Rao SU. Depression in adult dermatology outpatients. J Coll Physicians Surg Pak 2010; 20(12): 811-3.


Refbacks

  • There are currently no refbacks.


ISSN: 1560-9014